Literature DB >> 7843912

Relationship between natural killer cell susceptibility and metastasis of human uveal melanoma cells in a murine model.

D Ma1, G P Luyten, T M Luider, J Y Niederkorn.   

Abstract

PURPOSE: The purpose of this study was to determine the susceptibility of human uveal melanoma cells to in vitro and in vivo natural killer (NK) cell-mediated cytolysis and to determine if NK cells influence metastasis from the eye.
METHODS: Four human uveal melanoma cell lines and one melanoma cell line derived from a metastatic lesion from a patient with uveal melanoma were tested for in vitro and in vivo NK cell-mediated lysis in a mouse model. Major histocompatibility complex (MHC) class I antigen expression was evaluated by flow cytometry. The role of NK cells in controlling the metastasis of uveal melanoma cells from the eye to the liver was examined in nude mice.
RESULTS: Sensitivity to in vitro and in vivo lysis by human and murine NK cells was correlated with reduced expression of MHC class I antigens. Uveal melanoma lines expressing normal MHC class I antigen expression were insensitive to NK cell-mediated lysis, both in vitro and in vivo. Metastasis of uveal melanoma cells was inhibited by NK cell activity because disruption of in vivo NK function produced a sharp increase in the spontaneous metastasis of intraocular melanomas in nude mice.
CONCLUSIONS: There is considerable variation in the susceptibility of human uveal melanomas to NK cell-mediated cytolysis. Susceptibility is closely correlated with reduced expression of MHC class I antigen expression. Disruption of NK cell function significantly increases the development of hepatic metastases from human uveal melanoma cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7843912

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  24 in total

1.  Defective FasL expression is associated with increased resistance to melanoma liver metastases and enhanced natural killer cell activity.

Authors:  Sudha Neelam; Jessamee Mellon; Amber Wilkerson; Jerry Y Niederkorn
Journal:  Melanoma Res       Date:  2019-08       Impact factor: 3.599

Review 2.  Immune escape mechanisms of intraocular tumors.

Authors:  Jerry Y Niederkorn
Journal:  Prog Retin Eye Res       Date:  2009-06-27       Impact factor: 21.198

3.  HLA expression in a primary uveal melanoma, its cell line, and four of its metastases.

Authors:  D J Blom; L R Schurmans; I De Waard-Siebinga; D De Wolff-Rouendaal; J E Keunen; M J Jager
Journal:  Br J Ophthalmol       Date:  1997-11       Impact factor: 4.638

4.  Tumor vascularity and hematogenous metastasis in experimental murine intraocular melanoma.

Authors:  H E Grossniklaus
Journal:  Trans Am Ophthalmol Soc       Date:  1998

Review 5.  Uveal Melanoma Cell Lines: Where do they come from? (An American Ophthalmological Society Thesis).

Authors:  Martine J Jager; J Antonio Bermudez Magner; Bruce R Ksander; Sander R Dubovy
Journal:  Trans Am Ophthalmol Soc       Date:  2016-08

6.  Orthotopic human choroidal melanoma xenografts in nude rats with aggressive and nonaggressive PAS staining patterns.

Authors:  Rod D Braun; Asad Abbas
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-01       Impact factor: 4.799

Review 7.  Towards a vaccine to prevent cancer in Lynch syndrome patients.

Authors:  Magnus von Knebel Doeberitz; Matthias Kloor
Journal:  Fam Cancer       Date:  2013-06       Impact factor: 2.375

8.  Activated CD11b+ CD15+ granulocytes increase in the blood of patients with uveal melanoma.

Authors:  Kyle C McKenna; Kelly M Beatty; Richard A Bilonick; Lynn Schoenfield; Kira L Lathrop; Arun D Singh
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-04-15       Impact factor: 4.799

9.  Transforming growth factor-beta down-regulates major histocompatibility complex class I antigen expression and increases the susceptibility of uveal melanoma cells to natural killer cell-mediated cytolysis.

Authors:  D Ma; J Y Niederkorn
Journal:  Immunology       Date:  1995-10       Impact factor: 7.397

10.  Genomic characterization of explant tumorgraft models derived from fresh patient tumor tissue.

Authors:  David J Monsma; Noel R Monks; David M Cherba; Dawna Dylewski; Emily Eugster; Hailey Jahn; Sujata Srikanth; Stephanie B Scott; Patrick J Richardson; Robin E Everts; Aleksandr Ishkin; Yuri Nikolsky; James H Resau; Robert Sigler; Brian J Nickoloff; Craig P Webb
Journal:  J Transl Med       Date:  2012-06-18       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.